Abstract CT066: Phase 1 Study of MDM2 Antagonist ASTX295 in Patients with Solid Tumors with Wild-Type TP53
CANCER RESEARCH(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined